Berkshire Partners and Warburg Pincus are making a significant investment in Ensemble Health Partners that sources tell Sarah values the revenue cycle management company north of $5 billion.
Why it matters: From a valuation perspective, Ensemble, which one source adds is generating roughly $300 million of EBITDA, emerges as one of the year's largest health tech deals so far.
